Structural and functional abnormalities in iron-depleted heart.

Area of Science:

• Cardiology
• Cardiovascular Physiology
• Iron Metabolism

Background:

• Iron deficiency (ID) is a frequent comorbidity in heart failure (HF) and is linked to poorer patient outcomes, even without anemia.
• Systemic ID has been associated with cardiac functional and structural changes in animal models.
• The specific impact of myocardial iron deficiency, separate from systemic ID or anemia, remains unclear.

Purpose of the Study:

• To investigate the influence of cardiac-specific iron deficiency on heart tissue.
• To review the structural and functional cardiac consequences of ID in transgenic models.
• To summarize clinical data and discuss the benefits of iron supplementation in HF.

Main Methods:

• Review of existing literature on cardiac-specific iron deficiency models.
• Analysis of data from transgenic animal models with targeted myocardial ID.
• Synthesis of findings from relevant clinical studies.

Main Results:

• Cardiac-specific ID models reveal distinct structural and functional cardiac abnormalities.
• Myocardial ID contributes to cardiac dysfunction independently of systemic ID or anemia.
• Clinical studies support the negative impact of ID on HF outcomes.

Conclusions:

• Myocardial iron deficiency plays a significant role in the pathophysiology of heart failure.
• Targeting myocardial iron deficiency may offer therapeutic benefits for heart failure patients.
• Intravenous iron supplementation shows promise in improving outcomes for HF patients with ID.